Biosplice Therapeutics Funding: $778M Raised, Series E
Biosplice Therapeutics is based in San Diego. It has raised $778M in total funding. Latest round: Series E.
Biosplice Therapeutics funding overview
Biosplice Therapeutics is based in San Diego. Biosplice Therapeutics has raised $778M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in April 2021. The round record for Biosplice Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include SymBiosis Capital Management, Eventide Funds, aMoon, Polar Light Ventures, Ingka Investments, Vickers Venture Partners and 1 others. 7 distinct backers are named across the disclosed rounds.
Biosplice Therapeutics at a glance
Total raised
$778M
Latest round
Series E
Latest round date
April 2021
Headquarters
San Diego
Notable investors
SymBiosis Capital Management, Eventide Funds, aMoon, Polar Light Ventures, Ingka Investments, Vickers Venture Partners, Starling Group
Frequently asked about Biosplice Therapeutics funding
How much has Biosplice Therapeutics raised?
Biosplice Therapeutics has raised $778M in total disclosed funding across the rounds on record.
Who has invested in Biosplice Therapeutics?
SymBiosis Capital Management, Eventide Funds, aMoon, Polar Light Ventures, Ingka Investments, Vickers Venture Partners are named among the investors backing Biosplice Therapeutics.
What was the latest Biosplice Therapeutics funding round?
The most recent disclosed round is a Series E, announced in April 2021.
Where is Biosplice Therapeutics based?
Biosplice Therapeutics is based in San Diego.
When did Biosplice Therapeutics last raise?
The last disclosed Biosplice Therapeutics round closed in April 2021 at Series E.
Every Biosplice Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.
